These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. An update on sugammadex sodium. Welliver M; Cheek D AANA J; 2009 Jun; 77(3):219-28. PubMed ID: 19645172 [TBL] [Abstract][Full Text] [Related]
27. [Pharmacology of sugammadex]. Meistelman C; Fuchs-Buder T Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S51-6. PubMed ID: 19887278 [TBL] [Abstract][Full Text] [Related]
28. A novel approach to reversal of neuromuscular blockade. Della Rocca G; Pompei L Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157 [TBL] [Abstract][Full Text] [Related]
29. The Use of Sugammadex in a Patient With Guillain-Barre Syndrome: A Case Report. Tezcan B; Bölükbaşi D; Kazanci D; Turan S; Suer Kaya G; Özgök A A A Case Rep; 2017 Apr; 8(8):200-202. PubMed ID: 28151766 [TBL] [Abstract][Full Text] [Related]
30. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies. Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619 [TBL] [Abstract][Full Text] [Related]
31. [Extremely prolonged neuromuscular block after a single dose of rocuronium]. Menouni O; Brillouet-Banchereau AC; Galan G; Lélias A; Sautereau A; Gadrey S Ann Fr Anesth Reanim; 2011 Nov; 30(11):841-3. PubMed ID: 21983058 [TBL] [Abstract][Full Text] [Related]
32. Sugammadex: the first selective binding reversal agent for neuromuscular block. Kovac AL J Clin Anesth; 2009 Sep; 21(6):444-53. PubMed ID: 19833281 [TBL] [Abstract][Full Text] [Related]
33. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers. Cammu G; De Kam PJ; Demeyer I; Decoopman M; Peeters PA; Smeets JM; Foubert L Br J Anaesth; 2008 Mar; 100(3):373-9. PubMed ID: 18238834 [TBL] [Abstract][Full Text] [Related]
34. In vivo animal studies with sugammadex. Booij LH; van Egmond J; Driessen JJ; de Boer HD Anaesthesia; 2009 Mar; 64 Suppl 1():38-44. PubMed ID: 19222430 [TBL] [Abstract][Full Text] [Related]
35. Coronary vasospasm during the reversal of neuromuscular block using neostigmine. Kido K; Mizuta K; Mizuta F; Yasuda M; Igari T; Takahashi M Acta Anaesthesiol Scand; 2005 Oct; 49(9):1395-6. PubMed ID: 16146484 [No Abstract] [Full Text] [Related]
36. Use of Sugammadex in Patients With Obesity: A Pooled Analysis. Monk TG; Rietbergen H; Woo T; Fennema H Am J Ther; 2017; 24(5):e507-e516. PubMed ID: 26398716 [TBL] [Abstract][Full Text] [Related]
37. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship. Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699 [TBL] [Abstract][Full Text] [Related]
38. Prolonged neuromuscular blockade in a horse following concomitant use of vecuronium and atracurium. Gurney M; Mosing M Vet Anaesth Analg; 2012 Jan; 39(1):119-20. PubMed ID: 22118190 [No Abstract] [Full Text] [Related]
39. Drugs to facilitate recovery of neuromuscular blockade and muscle strength. Saitoh Y J Anesth; 2005; 19(4):302-8. PubMed ID: 16261467 [TBL] [Abstract][Full Text] [Related]